找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cardiorenal Syndrome; Mechanisms, Risk and Adel E. Berbari,Giuseppe Mancia Book 2010 Springer-Verlag Milan 2010 Chronic kidney disease.card

[复制链接]
楼主: T-cell
发表于 2025-3-25 04:47:27 | 显示全部楼层
Discussion And Conclusion Of The Study,iorenal association and to pinpoint features that are specific to each clinical entity, whether the initial insult is renal or cardiac. A detailed discussion of the various aspects of cardiorenal association are well covered in the following chapters.
发表于 2025-3-25 10:59:49 | 显示全部楼层
Novice Writers and Scholarly Publication 88% of patients with chronic kidney disease never reach end-stage renal disease, as the majority of them die due to cardiovascular disease. Thus, understanding the role of renal parenchymal disease as an independent cardiovascular risk state — i.e., renocardiac syndrome — is very important. In this
发表于 2025-3-25 12:35:01 | 显示全部楼层
发表于 2025-3-25 17:50:13 | 显示全部楼层
Novice Writers and Scholarly Publicationardiovascular events can be prevented. As the cardiorenal process advances, atherosclerotic vascular damage progresses, and subclinical organ damage can be detected. Chronic kidney disease is included at this stage, and a number of conditions associated with renal dysfunction become novel risk facto
发表于 2025-3-25 22:43:58 | 显示全部楼层
https://doi.org/10.1007/978-3-662-28359-2lanation as to why increased albuminuria not only predicts renal disease risk but also CVD risk. Treatments that lower albuminuria are associated with cardiovascular protection, as demonstrated in randomized controlled trials of diabetic as well as hypertensive patients. There is preliminary evidenc
发表于 2025-3-26 03:59:42 | 显示全部楼层
https://doi.org/10.1007/978-3-030-89877-9and vascular damage. In addition, the chapter reviews trial data that evaluated microalbuminuria for its prognostic significance on cardiovascular outcomes, as well as existing therapeutic interventions for reducing urinary albumin excretion in patients with high cardiovascular risk.
发表于 2025-3-26 08:20:06 | 显示全部楼层
发表于 2025-3-26 09:07:45 | 显示全部楼层
Progress in Inflammation Research lipid abnormalities. Beta blockers, aspirin and angiotensinconverting (ACE) inhibitors are likely effective therapies for treating coronary artery disease (CAD), but these remain very much underutilized. Similarly, despite evidence that coronary revascularization is useful in CKD and dialysis patie
发表于 2025-3-26 14:21:19 | 显示全部楼层
Strategies for Deep Customer Engagement, condition of this deadly syndrome, sometimes also called cardiorenal-anemia syndrome. In patients with heart failure, renal function has a powerful prognostic significance. This is true both in chronic heart failure over a long follow-up and in acutely decompensated heart failure for in-hospital mo
发表于 2025-3-26 20:52:25 | 显示全部楼层
everal uremia related factors such as uncontrolled hypertension, disturbed glucose insulin metabolism, microalbuminuria, phosphate retention, secondary hyperparathyroidism, myocardial and vascular calcification978-88-470-5609-1978-88-470-1463-3
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-29 03:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表